Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Ejhaem
|
April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project
Briony Shaw, Eliza Chung, Cameron Wellard, et al.
Haematologica
|
March 7, 2024
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, et al.
European Journal of Haematology
|
December 20, 2022
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry
James Nguyen, Cameron Wellard, Eliza Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2019
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
Blood Advances
|
April 9, 2020
LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma
Colm Keane, Soi C Law, Clare Gould, et al.
Blood
|
April 19, 2015
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
David M Kurtz, Michael R Green, Scott V Bratman, et al.
American Journal of Hematology
|
August 17, 2024
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma
Jay Gunawardana, Soi C Law, Muhammed B Sabdia, et al.
Ebiomedicine
|
December 4, 2024
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
Michael P MacManus, John F Seymour, Hennes Tsang, et al.
Leukemia & Lymphoma
|
March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort
Prashasti Agrawal, Kevin A David, Zhengming Chen, et al.
Cancer Discovery
|
March 24, 2026
Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment
Stephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Ejhaem
|
April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project
Briony Shaw, Eliza Chung, Cameron Wellard, et al.
Haematologica
|
March 7, 2024
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, et al.
European Journal of Haematology
|
December 20, 2022
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry
James Nguyen, Cameron Wellard, Eliza Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2019
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
Blood Advances
|
April 9, 2020
LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma
Colm Keane, Soi C Law, Clare Gould, et al.
Blood
|
April 19, 2015
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
David M Kurtz, Michael R Green, Scott V Bratman, et al.
American Journal of Hematology
|
August 17, 2024
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma
Jay Gunawardana, Soi C Law, Muhammed B Sabdia, et al.
Ebiomedicine
|
December 4, 2024
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
Michael P MacManus, John F Seymour, Hennes Tsang, et al.
Leukemia & Lymphoma
|
March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort
Prashasti Agrawal, Kevin A David, Zhengming Chen, et al.
Cancer Discovery
|
March 24, 2026
Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment
Stephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo, et al.
Page
of 7